Literature DB >> 21196275

CCN proteins in normal and injured liver.

Ralf Weiskirchen1.   

Abstract

CCN proteins are small secreted cysteine-rich proteins containing up to four individual structural modules including an insulin-like growth factor binding domain, a von Willebrand Factor type C motif, a thrombospondin type I module and a carboxyl-terminal cystine knot. Actually, there is a large body of evidence suggesting that members of the CCN protein family encompass an expansive repertoire of functions in crucial areas including control of development, cell fate, angiogenesis, tumorigenesis, osteogenesis, cell adhesion, mitogenesis, migration, chemotaxis, and cell survival. Moreover, this family is supposed to modulate signalling of integrins, transforming growth factor-betas, bone morphogenetic proteins, vascular endothelial growth factor, Notch and factors that mediate signals via the canonical Wingless-type MMTV integration site family. However, several of these properties are not substantiated by experimental data but were deduced from proteins sharing one or more of the structural modules with these proteins. In this review, the actual knowledge of biological activities and molecular involvement of CCN proteins in maintenance of liver health and in initiation and progression of hepatic diseases is summarized and discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196275     DOI: 10.2741/3832

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  12 in total

1.  CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.

Authors:  Erawan Borkham-Kamphorst; Claudia R van Roeyen; Eddy Van de Leur; Jürgen Floege; Ralf Weiskirchen
Journal:  J Cell Commun Signal       Date:  2011-07-05       Impact factor: 5.782

2.  Sesamol protects against liver fibrosis induced in rats by modulating lysophosphatidic acid receptor expression and TGF-β/Smad3 signaling pathway.

Authors:  Nesma A Abd Elrazik; Mohamed El-Mesery; Mamdouh M El-Shishtawy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-06-01       Impact factor: 3.195

Review 3.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

4.  Genetic characteristics of the human hepatic stellate cell line LX-2.

Authors:  Ralf Weiskirchen; Jörg Weimer; Steffen K Meurer; Anja Kron; Barbara Seipel; Inga Vater; Norbert Arnold; Reiner Siebert; Lieming Xu; Scott L Friedman; Carsten Bergmann
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

5.  Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein.

Authors:  Wilhelm Bohr; Michael Kupper; Kurt Hoffmann; Ralf Weiskirchen
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

6.  Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.

Authors:  Xia Liao; Yang Bu; Fan Chang; Fengan Jia; Ge Song; Xuelian Xiao; Mei Zhang; Pengbo Ning; Qingan Jia
Journal:  BMC Cancer       Date:  2019-12-05       Impact factor: 4.430

Review 7.  Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment.

Authors:  Claire E McQuitty; Roger Williams; Shilpa Chokshi; Luca Urbani
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

8.  Hepatic connective tissue growth factor expression and regulation differ between non-steatotic and non-alcoholic steatotic livers from brain-dead donor.

Authors:  Dong-Jing Yang; Ji-Hua Shi; Zong-Ping Xia; Wen-Zhi Guo; Mohammed Shakil Ahmed; Shui-Jun Zhang
Journal:  Sci Rep       Date:  2021-02-16       Impact factor: 4.379

Review 9.  CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?

Authors:  Qingan Jia; Qiongzhu Dong; Lunxiu Qin
Journal:  Oncotarget       Date:  2016-01-12

10.  Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.

Authors:  Qunfeng Wu; Marda Jorgensen; Joanna Song; Junmei Zhou; Chen Liu; Liya Pi
Journal:  Gastroenterol Res Pract       Date:  2016-10-18       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.